1. Scrip
  2. >>Focus On Asia
  3. >>India

With Mpox Vaccine In Serum Institute Pipeline, What Could Favor India Vaccine Makers?

 
• By Vibha Ravi

Serum Institute is working on an mpox vaccine while other Indian firms are weighing options after the WHO sounded an alert and a new case was reported in neighboring Pakistan. Scrip looks at factors that could favor development and/or manufacture of an mpox vaccine at Indian majors.

Stepping Up To Bat
Can Indian Firms Step Up To The Plate With An Mpox Vaccine? • Source: Shutterstock

India could step up to the plate with a vaccine to prevent mpox, classified as a public health emergency of international concern (PHEIC) once again post 2022 by the World Health Organization (WHO) after a new clade Ib variant of the virus emerged this year.

Serum Institute of India Pvt. Ltd., partner to AstraZeneca PLC and Novavax, Inc

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from India

More from Focus On Asia